OCULIS
The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow diseases at the anterior part of the eye to be treated with a reduced number of topical applications compared to conventional eye-drops.
OCULIS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2003-01-01
Address:
Reykjavík, Gullbringusysla, Iceland
Country:
Iceland
Website Url:
http://www.oculis.com
Total Employee:
11+
Status:
Active
Contact:
+354 546-4440
Email Addresses:
[email protected]
Total Funding:
94.36 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Hyfinity Investments
Hyfinity Investments investment in Series C - Oculis
Bay City Capital
Bay City Capital investment in Series C - Oculis
Nan Fung Life Sciences
Nan Fung Life Sciences investment in Series C - Oculis
BVCF
BVCF investment in Series C - Oculis
Tekla Capital Management
Tekla Capital Management investment in Series C - Oculis
Silfurberg
Silfurberg investment in Series C - Oculis
Brunnur Ventures
Brunnur Ventures investment in Series C - Oculis
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series C - Oculis
VI Partners
VI Partners investment in Series C - Oculis
Novartis Venture Fund
Novartis Venture Fund investment in Series C - Oculis
Key Employee Changes
Official Site Inspections
http://www.oculis.com Semrush global rank: 3.27 M Semrush visits lastest month: 5.03 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Oculis"
About Us - Ophthalmology Companies - Oculis
Oculis is a global biopharmaceutical company purposefully driven to save sight and improve eye care. We are driven by patients suffering from eye diseases to develop transformative innovations that have the potential to address …See details»
Meet Our Team - Oculis
We are a global biopharmaceutical company purposefully driven to save sight and improve eye care. Led by an experienced management team and supported by leading investors and …See details»
Oculis - Crunchbase Company Profile & Funding
The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow …See details»
Oculis | Investors and Media
Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple …See details»
Oculis | Oculis Publishes Results of 2024 Annual General Meeting …
ZUG, Switzerland, May 30, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company purposefully …See details»
Oculis Holding - Overview, News & Similar companies - ZoomInfo
Aug 12, 2024 Who is Oculis Holding. Headquartered in Zug, Switzerland with global operations in Europe, the U.S. and China. Oculis is a biopharmaceutical company focused on developing …See details»
Oculis Operations Sàrl – Swiss Biotech
Oculis is a biopharmaceutical company purposefully driven to save sight & improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in …See details»
Oculis - Funding, Financials, Valuation & Investors - Crunchbase
Oculis is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
Oculis Company Profile - Office Locations, Competitors, Revenue …
Oculis is a biopharmaceutical company focused on eye care. Its products include OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for …See details»
Oculis - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Oculis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... including Chief Medical Officer & Co-Founder Einar …See details»
Oculis Announces US Public Listing on NASDAQ
Mar 3, 2023 LAUSANNE and ZUG, Switzerland, March 3, 2023 – Oculis Holding AG (“Oculis”) a global biopharmaceutical company purposefully driven to save sight and improve eye care, …See details»
Meta Developers - Oculus VR
Create your organization. Add financial settings. Get financial reports. Verify your org. Manage multiple orgs. Manage test users. Business models and strategy. Overview. Offer add-ons …See details»
Oculis appoints Rebecca Weil, PhD, as chief commercial officer
Sep 11, 2023 Oculis has announced the appointment of Rebecca Weil, PhD, as chief commercial officer. The announcement, which came in the way of a press release from the …See details»
Oculus
Oculus Casting allows you to stream VR experiences from Oculus Quest or Quest 2 to your smartphone or tablet.See details»
Our Culture: Mission To Save Sight & Improve Eye Care- Oculis
At Oculis, we believe that a thriving culture is an essential component of our success. We are committed to creating and fostering a positive environment where our employees can bring …See details»
Oculis - Your Local General Contractor and Handyman
Enhance the security and organization of your event or construction site with our top-notch Fence Rentals. We offer a diverse range of fencing options, from Temporary Fence Panels and Post …See details»
Rethinking Ophthalmology - Oculis
Aug 8, 2023 Oculis announces positive top line results from DIAMOND Stage 1 phase 3 trial in diabetic macular edema with OCS-01 eye drops. .May 22, 2023. 3. Shulman S, et al. Acta …See details»
Oculis Holding AG: Dual-Listing Milestone and Strategic Capital ...
5 days ago Investors will closely monitor Oculis's strategic alignment with market demands, its innovation pipeline, and its ability to leverage the dual-market advantage. These factors will …See details»
Oculis Labs - Crunchbase Company Profile & Funding
Organization. Oculis Labs . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Oculis Labs is a security company providing …See details»
Oculis’ acute optic neuritis therapy trial meets primary endpoint
1 day ago Oculis CEO Riad Sherif said: “These positive safety and efficacy results from ACUITY represent a significant milestone in bringing the first potential neuroprotective treatment in …See details»